Show simple item record

dc.date.accessioned2019-09-11T13:45:58Z
dc.date.available2019-09-11T13:45:58Z
dc.date.issued2017-11-27
dc.identifier.urihttp://hdl.handle.net/10713/10527
dc.descriptionNews release discussing the UMB Center for Vaccine Development's, Vaccine Impact on Diarrhea in Africa (VIDA) project, led by Karen Kotloff, MD. The study began 14 to 21 months subsequent to the introduction of rotavirus vaccines in The Gambia, Mali, and Kenya. Vaccination impact will be assessed by comparing before and after data associated with the etiology and incidence of moderate-to-severe diarrhea in children 0-59 months.en_US
dc.language.isoen_USen_US
dc.publisherUniversity of Maryland, Baltimore. Office of Public Affairsen_US
dc.subjectUniversity of Maryland, Baltimore. Center for Vaccine Developmenten_US
dc.subject.meshRotavirus Vaccineen_US
dc.subject.meshGambiaen_US
dc.subject.meshKenyaen_US
dc.subject.meshMalien_US
dc.titleAnalyzing the Impact of a Rotavirus Vaccine in Africaen_US
dc.typeArticleen_US
refterms.dateFOA2019-09-11T13:45:58Z


Files in this item

Thumbnail
Name:
AnalyzingTheImpactOfARotavirus ...
Size:
321.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record